This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Aluminium glycinate is a medication indicated to treat heartburn, indigestion, acid reflux, ulcers, and gas.
- Generic Name
- Aluminium glycinate
- DrugBank Accession Number
- DB13626
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Aluminium glycinate (DB13626)
- Weight
- Average: 153.07
Monoisotopic: 153.0217859 - Chemical Formula
- C2H8AlNO5
- Synonyms
- Aluminio glicinato
- Aluminum glycinate
- Dihydroxyaluminum aminoacetate
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcetaminophen Aluminium glycinate can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy. Acetophenazine Aluminium glycinate can cause a decrease in the absorption of Acetophenazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Alendronic acid The serum concentration of Alendronic acid can be decreased when it is combined with Aluminium glycinate. Alimemazine Aluminium glycinate can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Allopurinol The therapeutic efficacy of Allopurinol can be decreased when used in combination with Aluminium glycinate. Amphetamine The serum concentration of Amphetamine can be increased when it is combined with Aluminium glycinate. Amprenavir Aluminium glycinate can cause a decrease in the absorption of Amprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy. Asunaprevir Aluminium glycinate can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy. Atazanavir Aluminium glycinate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy. Beclomethasone dipropionate The bioavailability of Beclomethasone dipropionate can be decreased when combined with Aluminium glycinate. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image อาโมจิน Aluminium glycinate (250 MG) + Magnesium trisilicate (250 MG) Tablet บริษัท โมเดิร์น ฟาร์มา จำกัด 2013-01-14 Not applicable Thailand 
Categories
- ATC Codes
- A02AB07 — Aluminium glycinate
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- DO250MG0W6
- CAS number
- 41354-48-7
- InChI Key
- UTUUIUQHGDRVPU-UHFFFAOYSA-K
- InChI
- InChI=1S/C2H5NO2.Al.3H2O/c3-1-2(4)5;;;;/h1,3H2,(H,4,5);;3*1H2/q;+3;;;/p-3
- IUPAC Name
- aluminium(3+) 2-aminoacetate hydrate dihydroxide
- SMILES
- O.[OH-].[OH-].[Al+3].NCC([O-])=O
References
- General References
- FDA Thailand: Amogin (Aluminum Glycinate) Oral Tablet [Link]
- External Links
- ChemSpider
- 34990037
- 23162
- Wikipedia
- Aluminium_glycinate
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 30.6 mg/mL ALOGPS logP -1.2 ALOGPS logP -3.4 Chemaxon logS -0.64 ALOGPS pKa (Strongest Acidic) 2.31 Chemaxon pKa (Strongest Basic) 9.24 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 66.15 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 26.84 m3·mol-1 Chemaxon Polarizability 6.25 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at June 23, 2017 20:45 / Updated at May 29, 2021 18:12